Literature DB >> 15161810

Diabetes complications.

Zachary T Bloomgarden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15161810     DOI： 10.2337/diacare.27.6.1506

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  18 in total

1.  The impact of diabetes on the outcomes of surgical and nonsurgical treatment of patients in the spine patient outcomes research trial.

Authors:  Mitchell K Freedman; Alan S Hilibrand; Emily A Blood; Wenyan Zhao; Todd J Albert; Alexander R Vaccaro; Christina V Oleson; Tamara S Morgan; James N Weinstein
Journal:  Spine (Phila Pa 1976)       Date:  2011-02-15       Impact factor: 3.468

2.  Monitoring neovascularization of intraportal islet grafts by dynamic contrast enhanced magnetic resonance imaging.

Authors:  Nathaniel K Chan; Andre Obenaus; Annie Tan; Naoaki Sakata; John Mace; Ricardo Peverini; Richard Chinnock; Lawrence C Sowers; Eba Hathout
Journal:  Islets       Date:  2009-11       Impact factor: 2.694

3.  Economic Model Predictive Control of Bihormonal Artificial Pancreas System Based on Switching Control and Dynamic R-parameter.

Authors:  Fengna Tang; Youqing Wang
Journal:  J Diabetes Sci Technol       Date:  2017-07-21

4.  Impact of islet transplantation on diabetes complications and quality of life.

Authors:  Roberto Bassi; Paolo Fiorina
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

5.  Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.

Authors:  Moufida Ben Nasr; Andrea Vergani; James Avruch; Liye Liu; Eirini Kefaloyianni; Francesca D'Addio; Sara Tezza; Domenico Corradi; Roberto Bassi; Alessandro Valderrama-Vasquez; Vera Usuelli; James Kim; Jamil Azzi; Basset El Essawy; James Markmann; Reza Abdi; Paolo Fiorina
Journal:  Acta Diabetol       Date:  2015-03-27       Impact factor: 4.280

6.  Biologic and immunomodulatory properties of mesenchymal stromal cells derived from human pancreatic islets.

Authors:  Jaehyup Kim; Melissa J Breunig; Leah E Escalante; Neehar Bhatia; Ryan A Denu; Bridget A Dollar; Andrew P Stein; Summer E Hanson; Nadia Naderi; James Radek; Dermot Haughy; Debra D Bloom; Fariba M Assadi-Porter; Peiman Hematti
Journal:  Cytotherapy       Date:  2012-05-09       Impact factor: 5.414

7.  Perfusion-decellularized pancreas as a natural 3D scaffold for pancreatic tissue and whole organ engineering.

Authors:  Saik-Kia Goh; Suzanne Bertera; Phillip Olsen; Joseph E Candiello; Willi Halfter; Guy Uechi; Manimalha Balasubramani; Scott A Johnson; Brian M Sicari; Elizabeth Kollar; Stephen F Badylak; Ipsita Banerjee
Journal:  Biomaterials       Date:  2013-06-17       Impact factor: 12.479

Review 8.  Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes.

Authors:  Ionel Sandovici; Constanze M Hammerle; Susan E Ozanne; Miguel Constância
Journal:  Cell Mol Life Sci       Date:  2013-03-06       Impact factor: 9.261

Review 9.  Current achievements and future perspectives in whole-organ bioengineering.

Authors:  Andrea Peloso; Abritee Dhal; Joao P Zambon; Peng Li; Giuseppe Orlando; Anthony Atala; Shay Soker
Journal:  Stem Cell Res Ther       Date:  2015-06-01       Impact factor: 6.832

10.  Effect of the purinergic inhibitor oxidized ATP in a model of islet allograft rejection.

Authors:  Andrea Vergani; Carmen Fotino; Francesca D'Addio; Sara Tezza; Michele Podetta; Francesca Gatti; Melissa Chin; Roberto Bassi; Ruth D Molano; Domenico Corradi; Rita Gatti; Maria E Ferrero; Antonio Secchi; Fabio Grassi; Camillo Ricordi; Mohamed H Sayegh; Paola Maffi; Antonello Pileggi; Paolo Fiorina
Journal:  Diabetes       Date:  2013-01-11       Impact factor: 9.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.